Big money! Samsung Hao invested $360 billion in chip and biotechnology business

According to CNMO, Samsung Group said on May 24 that it plans to increase spending by more than 30% to 450 trillion won (about US $360 billion) over the next five years. About 360 trillion won will be used for domestic investment and the rest for overseas investment. At present, Samsung Electronics, a subsidiary of SamSung group, is building a $17 billion advanced chip factory in Texas. Samsung Group intends to increase investment to strengthen its business capabilities in chip and pharmaceutical fields, so as to deal with the increasingly serious economic and supply shortage.

In addition, Samsung Group also promised in the statement that it would create 80000 jobs by 2026, mainly in the fields of semiconductors and biopharmaceuticals. It is reported that Samsung Electronics and Samsung biological agents and other subsidiaries of SamSung group play an important supporting function for the Korean economy. Therefore, the 80000 jobs provided by Samsung Group will help South Korean people increase their economic income to a certain extent.

As the world's second-largest chip supplier, Samsung has been committed to improving its industry position. This time, spending a lot of money to strengthen the chip and biotechnology business may enhance Samsung's chip R & D and production capacity and further enhance its position in the industry.